283 reports of this reaction
1.5% of all ICOSAPENT ETHYL reports
#12 most reported adverse reaction
BLOOD TRIGLYCERIDES INCREASED is the #12 most commonly reported adverse reaction for ICOSAPENT ETHYL, manufactured by Amarin Pharma Inc.. There are 283 FDA adverse event reports linking ICOSAPENT ETHYL to BLOOD TRIGLYCERIDES INCREASED. This represents approximately 1.5% of all 18,725 adverse event reports for this drug.
Patients taking ICOSAPENT ETHYL who experience blood triglycerides increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD TRIGLYCERIDES INCREASED is a less commonly reported adverse event for ICOSAPENT ETHYL, but still significant enough to appear in the safety profile.
In addition to blood triglycerides increased, the following adverse reactions have been reported for ICOSAPENT ETHYL:
The following drugs have also been linked to blood triglycerides increased in FDA adverse event reports:
BLOOD TRIGLYCERIDES INCREASED has been reported as an adverse event in 283 FDA reports for ICOSAPENT ETHYL. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD TRIGLYCERIDES INCREASED accounts for approximately 1.5% of all adverse event reports for ICOSAPENT ETHYL, making it a notable side effect.
If you experience blood triglycerides increased while taking ICOSAPENT ETHYL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.